Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Venous Return01:04

Venous Return

The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system as it...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression to Chronic Limb-Threatening Ischemia After Index Revascularization for Claudication.

JAMA surgery·2025
Same author

The My PAD study for patient-reported outcomes for peripheral vascular intervention in the Vascular Quality Initiative.

Journal of vascular surgery·2025
Same author

Management of claudication in older adults and the role of exercise therapy.

Seminars in vascular surgery·2025
Same author

Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update.

Journal of vascular surgery·2025
Same author

Prescriber implementation of guideline-directed medical therapy remains poor in the peripheral artery disease population.

Journal of vascular surgery·2025
Same author

Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy.

JVS-vascular insights·2025
Same journal

Mitral valve dysplasia associated with left ventricular non-compaction cardiomyopathy and papillary muscle hypertrophy: a case report.

Future cardiology·2026
Same journal

Cardio-oncology awareness: a multidisciplinary survey among trainees and practicing professionals at multidisciplinary settings.

Future cardiology·2026
Same journal

Wearable devices for atrial fibrillation: diagnostic and screening roles of ECG and PPG-A systematic review.

Future cardiology·2026
Same journal

Impact of comorbid mental disorders on in‑hospital mortality and complications after ST‑segment elevation myocardial infarction.

Future cardiology·2026
Same journal

Endovascular revascularisation of lower-extremity peripheral arterial disease: technical and clinical outcomes in a Vietnamese single-center prospective cohort study.

Future cardiology·2026
Same journal

Ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism: current evidence, limitations, and future directions.

Future cardiology·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Rodent Inferior Vena Cava Venoplasty Balloon Model
05:44

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Vena cava filters: an update.

Matthew A Corriere1, K Todd Piercy, Matthew S Edwards

  • 1Department of General Surgery, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. mcorrier@wfubmc.edu

Future Cardiology
|October 7, 2009
PubMed
Summary
This summary is machine-generated.

Vena cava filters prevent pulmonary embolism when anticoagulation fails. Recent innovations and controversial prophylactic use are discussed, alongside indications, complications, and devices.

More Related Videos

Sequential Blood Collection from Inferior Vena Cava Followed by Portal Vein to Evaluate Gut Microbial Metabolites in Mice
04:09

Sequential Blood Collection from Inferior Vena Cava Followed by Portal Vein to Evaluate Gut Microbial Metabolites in Mice

Published on: June 21, 2024

Related Experiment Videos

Last Updated: Jun 19, 2026

Rodent Inferior Vena Cava Venoplasty Balloon Model
05:44

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Sequential Blood Collection from Inferior Vena Cava Followed by Portal Vein to Evaluate Gut Microbial Metabolites in Mice
04:09

Sequential Blood Collection from Inferior Vena Cava Followed by Portal Vein to Evaluate Gut Microbial Metabolites in Mice

Published on: June 21, 2024

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Medical Devices

Background:

  • Venous thromboembolism (VTE) poses significant health risks, including mortality and long-term complications.
  • Managing VTE can be challenging, especially when anticoagulation is contraindicated or insufficient.
  • Vena cava filters offer protection against pulmonary embolism in specific patient populations.

Purpose of the Study:

  • To review the indications for vena cava filter insertion.
  • To discuss associated complications and current FDA-approved devices.
  • To provide a historical perspective on caval filtration and recent innovations.

Main Methods:

  • Review of current literature on vena cava filters.
  • Analysis of indications, complications, and imaging modalities for filter insertion.
  • Examination of temporary caval filtration devices and prophylactic use controversies.

Main Results:

  • Vena cava filters are indicated for patients with contraindications or inadequacy of anticoagulation.
  • Innovations include alternative imaging and temporary filter devices.
  • There is a controversial increase in prophylactic vena cava filter use.

Conclusions:

  • Vena cava filters are crucial for preventing pulmonary embolism in select VTE patients.
  • Technological advancements are expanding filter applications.
  • Careful consideration of indications and potential complications is essential, particularly regarding prophylactic use.